Psychopharmacology

, Volume 179, Issue 4, pp 895–896

Dizziness produced by a potent 5HT1A receptor agonist (eptapirone) is not due to postural hypotension

Letter to the Editors

References

  1. Coupland NJ, Bailey JE, Wilson SJ, Horvath R, Nutt DJ (1995a) The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clinic Auton Res 5:171–177Google Scholar
  2. Coupland NJ, Wilson SJ, Potokar J, Bell CE, Bailey JE, Nutt DJ (1995b) A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmacol 10:229–238Google Scholar
  3. Coupland NJ, Bell CJ, Potokar JP (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 16(5):356–362CrossRefGoogle Scholar
  4. De Bruyn S, Tournoux A, Deprez D, Pezous N, Lafon M (2002) Study of the tolerability, pharmacodynamics and pharmacokinetics of F 11440 administered in repeated doses for 14 days Pierre Fabre internal report No L0068 GE 101Google Scholar
  5. Driver HS, Flanigan MJ, Bentley AJ, Luus HG, Shapiro CM, Mitchell D (1995) The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology (Berl) 117(2):186–192Google Scholar
  6. Koek W, Patoiseau JF, Assie MB, Cosi C, Kleven MS, Dupont-Passelaigue E, Carilla-Durand E, Palmier C, Valentin JP, John G, Pauwels PJ, Tarayre JP, Colpaert FC (1998) F11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. J Pharmacol Exp Ther 287:266–283Google Scholar
  7. Robinson DS, Sitsen JM, Gibertini M (2003) A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone. Clin Ther 25(6):1618–1633CrossRefGoogle Scholar
  8. Sramek JJ, Hong WW, Hamid S, Nape B, Cutler NR (1999) Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety. Depress Anxiety 9(3):131–134Google Scholar
  9. van der Post J, Schram MT, Schoemaker RC, Pieters MS, Fuseau E, Pereira A, Baggen S, Cohen AF, van Gerven JM (2002) CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia 22(4):271–281CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Psychopharmacology UnitUniversity of BristolBristolUK

Personalised recommendations